Most Read News

Reported sales nil

Sales decline 11.30% to Rs 77857.16 crore

The offer received bids for 1.45 crore shares as against 6.25 crore shares on offer.

The offer received bids for 73.30 lakh shares as against 60.18 lakh shares on offer.

At 77.6075/6100 per Dollar

The offer received bids for 1.57 crore shares as against 35.51 lakh shares on offer.

Sales rise 14.34% to Rs 122.13 crore

Zim Laboratories announced today that AEPMS – The Spanish Agency for Medicine and Healthcare Products has granted Marketing Authorisation for its innovative product Sildenafil 50 mg ODS in Spain to its wholly owned European Subsidiary – SIA ZIM Laboratories. ZIM Labs is a pioneer in developing Oral Thin Films (OTF) an innovative and novel drug delivery dosage form. The above product is developed using patented […]

Axis Bank announced that credit rating agency India Ratings and Research (Ind-Ra) has affirmed the Banks Long-Term Issuer Rating at IND AAA with a Stable Outlook and Short-Term Issuer Rating at IND A1+ . The instrument-wise rating actions are as follows: Basel III compliant Tier 2 bonds – IND AAA/Stable (affirmed) Basel III compliant AT1 bonds – IND AA+/ Stable (affirmed) Powered by Capital Market […]

With effect from 12 May 2022